Monogram Technologies ( NASDAQ: MGRM ) on Monday announced its strategic collaboration with Shalby Limited, to conduct a multicenter clinical trial to demonstrate the safety and effectiveness of the mBȏs TKA System. Under the collaboration, Shalby will enroll patients at various sites in India for surgeons to evaluate the safety and effectiveness of the mBȏs TKA System with the Consensus CKS implant, which is substantially equivalent to the Monogram mPress implants for regulatory purposes. The collaboration contemplates the post-trial transfer of a robot to the hospital system under certain conditions following the trial, as the companies contemplate further collaboration.
Press release. More on Monogram Technologies Inc. Monogram Technologies Inc.
(MGRM) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Monogram Technologies Inc. Historical earnings data for Monogram Technologies Inc. Financial information for Monogram Technologies Inc.
.
